PetLife Pharmaceuticals, Inc. 4
4 · PetLife Pharmaceuticals, Inc. · Filed Mar 24, 2017
Insider Transaction Report
Form 4
Campbell Vyvyan
Director10% Owner
Transactions
- Award
Common Stock
2016-10-27$0.50/sh+1,200,000$600,000→ 1,568,680 total - Purchase
Common Stock
2015-05-30$0.75/sh+50,210$37,658→ 50,210 total - Purchase
Common Stock
2015-11-09$0.25/sh+100,000$25,000→ 150,210 total - Purchase
Common Stock
2016-05-15$1.25/sh+218,470$273,088→ 368,680 total - Purchase
Common Stock
2017-02-23$0.25/sh+40,000$10,000→ 1,608,680 total - Award
Common Stock
2017-02-23$0.50/sh+9,484,555$4,742,278→ 9,484,555 total(indirect: By Trust)
Footnotes (3)
- [F1]Adjusted for the issuer's 1-for-5 reverse stock split effected in September 2016.
- [F2]For services valued at $0.50/share.
- [F3]Ms. Campbell is the trustee of the trust and has sole voting and dispositive power with respect to shares held in the name of the trust.